PL1668003T3 - Benzoizoksazole - Google Patents

Benzoizoksazole

Info

Publication number
PL1668003T3
PL1668003T3 PL04787069T PL04787069T PL1668003T3 PL 1668003 T3 PL1668003 T3 PL 1668003T3 PL 04787069 T PL04787069 T PL 04787069T PL 04787069 T PL04787069 T PL 04787069T PL 1668003 T3 PL1668003 T3 PL 1668003T3
Authority
PL
Poland
Prior art keywords
benzisoxazoles
pharmaceuticals
reversible
preparation
fatty acid
Prior art date
Application number
PL04787069T
Other languages
English (en)
Inventor
Joachim Nozulak
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1668003T3 publication Critical patent/PL1668003T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
PL04787069T 2003-10-01 2004-09-30 Benzoizoksazole PL1668003T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0322994.5A GB0322994D0 (en) 2003-10-01 2003-10-01 Organic compounds
EP04787069A EP1668003B1 (en) 2003-10-01 2004-09-30 Benzisoxazoles
PCT/EP2004/010938 WO2005030763A1 (en) 2003-10-01 2004-09-30 Benzisoxazoles

Publications (1)

Publication Number Publication Date
PL1668003T3 true PL1668003T3 (pl) 2008-05-30

Family

ID=29415309

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04787069T PL1668003T3 (pl) 2003-10-01 2004-09-30 Benzoizoksazole

Country Status (13)

Country Link
US (7) US20070197595A1 (pl)
EP (1) EP1668003B1 (pl)
JP (2) JP2007507455A (pl)
AT (1) ATE378331T1 (pl)
CY (1) CY1107277T1 (pl)
DE (1) DE602004010161T2 (pl)
DK (1) DK1668003T3 (pl)
ES (1) ES2297493T3 (pl)
GB (1) GB0322994D0 (pl)
PL (1) PL1668003T3 (pl)
PT (1) PT1668003E (pl)
SI (1) SI1668003T1 (pl)
WO (1) WO2005030763A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds
US9000221B2 (en) 2010-09-07 2015-04-07 Symed Labs Limited Processes for the preparation of 4′-[3-[4-(6-Fluoro-1 ,2-benzisoxazol-3-yl)piperidino]propoxy]-3′-methoxyacetophenone and intermediates thereof
CA2865845C (en) * 2012-03-14 2020-02-18 Vanda Pharmaceuticals Inc. An iloperidone metabolite for use in the treatment of psychiatric disorders

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5158952A (en) * 1988-11-07 1992-10-27 Janssen Pharmaceutica N.V. 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
IL119095A (en) * 1996-08-19 2000-06-01 Mul T Lock Technologies Ltd Lock housing
US6225321B1 (en) * 1997-06-05 2001-05-01 Oliver Yoa-Pu Hu Long analgesic acting nalbuphine polyester derivative and method of use
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
ES2387562T3 (es) * 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
JP2005504783A (ja) * 2001-08-31 2005-02-17 ノバルティス アクチエンゲゼルシャフト イロペリドン代謝産物の光学異性体
CA2529857A1 (en) * 2002-07-30 2004-02-05 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
GB0322994D0 (en) * 2003-10-01 2003-11-05 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
JP5794667B2 (ja) 2015-10-14
GB0322994D0 (en) 2003-11-05
WO2005030763A1 (en) 2005-04-07
US20200131166A1 (en) 2020-04-30
DE602004010161D1 (de) 2007-12-27
ATE378331T1 (de) 2007-11-15
US20110172272A1 (en) 2011-07-14
CY1107277T1 (el) 2012-11-21
EP1668003A1 (en) 2006-06-14
US20170129878A1 (en) 2017-05-11
JP2007507455A (ja) 2007-03-29
DE602004010161T2 (de) 2008-10-30
PT1668003E (pt) 2007-12-31
SI1668003T1 (sl) 2008-04-30
EP1668003B1 (en) 2007-11-14
US20180118729A1 (en) 2018-05-03
US20070197595A1 (en) 2007-08-23
JP2011157377A (ja) 2011-08-18
ES2297493T3 (es) 2008-05-01
US20190276444A1 (en) 2019-09-12
DK1668003T3 (da) 2008-03-03
US20190055228A1 (en) 2019-02-21

Similar Documents

Publication Publication Date Title
UA102534C2 (xx) ТВЕРДА ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДІОКСОЛ-5-ІЛ)-ЦИКЛОПРОПАНКАРБОКСАМІДО)-3-МЕТИЛПІРИДИН-2-ІЛ)БЕНЗОЙНОЇ КИСЛОТИ (ВАРІАНТИ)$ТВЕРДАЯ ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДИОКСОЛ-5-ИЛ)-ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ (ВАРИАНТЫ)
UA95199C2 (en) Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
MX2007014892A (es) Formas polimorficas del ester etilico del acido 3-[(2-{[4-(hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}- 1-metil-h-bencimidazol-5-carbonil)-piridin-2-il--amino]propionico .
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
TW200514772A (en) Novel tetrahydropyridine derivatives
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
TW200626593A (en) Novel compounds
TW200716568A (en) 1H-quinazoline-2,4-diones
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
TW200745122A (en) New compounds I
CY1107277T1 (el) Βενζισοξαζολες
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
TW200621773A (en) Bicyclononene derivatives
WO2008152260A3 (fr) Nouveaux ligands agonistes des recepteurs rars, utilisation en medecine humaine ainsi qu'en cosmetique
WO2005056510A3 (en) Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
GEP20125563B (en) 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи
WO2006110185A3 (en) Antiinfective lipopeptides
WO2006103119A3 (en) Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics